The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soane, L.
Right arrow Articles by Shin, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soane, L.
Right arrow Articles by Shin, M. L.
The Journal of Immunology, 2001, 167: 2305-2311.
Copyright © 2001 by The American Association of Immunologists

C5b-9 Terminal Complement Complex Protects Oligodendrocytes from Death by Regulating Bad Through Phosphatidylinositol 3-Kinase/Akt Pathway1

Lucian Soane*, Hyun-Jun Cho*, Florin Niculescu{ddagger}, Horea Rus*,{dagger} and Moon L. Shin2,*

Departments of * Pathology and {dagger} Neurology and {ddagger} Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201

Apoptosis of oligodendrocytes is induced by serum growth factor deprivation. We showed that oligodendrocytes and progenitor cells respond to serum withdrawal by a rapid decline of Bcl-2 mRNA expression and caspase-3-dependent apoptotic death. Sublytic assembly of membrane-inserted terminal complement complexes consisting of C5b, C6, C7, C8, and C9 proteins (C5b-9) inhibits caspase-3 activation and apoptotic death of oligodendrocytes. In this study, we examined an involvement of the mitochondria in oligodendrocyte apoptosis and the role of C5b-9 on this process. Decreased phosphatidylinositol 3-kinase and Akt activities occurred in association with cytochrome c release and caspase-9 activation when cells were placed in defined medium. C5b-9 inhibited the mitochondrial pathway of apoptosis in oligodendrocytes, as shown by decreased cytochrome c release and inhibition of caspase-9 activation. Phosphatidylinositol 3-phosphate kinase and Akt activities were also induced by C5b-9, and the phosphatidylinositol 3-phosphate kinase inhibitor LY294002 reversed the protective effect of C5b-9. Phosphatidylinositol 3-phosphate kinase activity was also responsible for the phosphorylation of Bad at Ser112 and Ser136. This phosphorylation resulted in dissociation of Bad from the Bad/Bcl-xL complex in a Gi{alpha}-dependent manner. The mitochondrial pathway of oligodendrocyte apoptosis is, therefore, inhibited by C5b-9 through post-translational regulation of Bad. This mechanism may be involved in the promotion of oligodendrocyte survival in inflammatory demyelinating disorders affecting the CNS.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. A. Watson, J. E. B. Reusch, S. A. McCune, L. A. Leinwand, S. W. Luckey, J. P. Konhilas, D. A. Brown, A. J. Chicco, G. C. Sparagna, C. S. Long, et al.
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H246 - H259.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fosbrink, F. Niculescu, V. Rus, M. L. Shin, and H. Rus
C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1
J. Biol. Chem., July 14, 2006; 281(28): 19009 - 19018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Cudrici, F. Niculescu, T. Jensen, E. Zafranskaia, M. Fosbrink, V. Rus, M. L. Shin, and H. Rus
C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP.
J. Immunol., March 1, 2006; 176(5): 3173 - 3180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. F. Grehan, B. K. Levay-Young, J. L. Fogelson, V. Francois-Bongarcon, B. A. Benson, and A. P. Dalmasso
IL-4 and IL-13 Induce Protection of Porcine Endothelial Cells from Killing by Human Complement and from Apoptosis through Activation of a Phosphatidylinositide 3-Kinase/Akt Pathway
J. Immunol., August 1, 2005; 175(3): 1903 - 1910.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q.-L. Cui, W.-H. Zheng, R. Quirion, and G. Almazan
Inhibition of Src-like Kinases Reveals Akt-dependent and -independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival
J. Biol. Chem., March 11, 2005; 280(10): 8918 - 8928.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Niculescu, S. Weerth, F. Niculescu, C. Cudrici, V. Rus, C. S. Raine, M. L. Shin, and H. Rus
Effects of Complement C5 on Apoptosis in Experimental Autoimmune Encephalomyelitis
J. Immunol., May 1, 2004; 172(9): 5702 - 5706.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. H. Weerth, H. Rus, M. L. Shin, and C. S. Raine
Complement C5 in Experimental Autoimmune Encephalomyelitis (EAE) Facilitates Remyelination and Prevents Gliosis
Am. J. Pathol., September 1, 2003; 163(3): 1069 - 1080.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. P. Mycko, R. Papoian, U. Boschert, C. S. Raine, and K. W. Selmaj
cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity
Brain, May 1, 2003; 126(5): 1048 - 1057.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Molina-Holgado, J. M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and C. Guaza
Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling
J. Neurosci., November 15, 2002; 22(22): 9742 - 9753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.